(Q43680127)

25 November 2017

title

Chymostatin has no apparent beneficial effect on muscular dystrophy in the mdx mouse (English)

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

3 January 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

3 January 2023

author name string

K. N. Christie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3379449

3 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3379449

3 January 2023

publication date

1 April 1988

1 reference

full work available at URL

25 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0022510X88901384?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

https://api.elsevier.com/content/article/PII:0022510X88901384?httpAccept=text/plain

3 January 2023

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Journal of the Neurological Sciences

3 January 2023

published in

1 reference

25 November 2017

volume

84

1 reference

25 November 2017

issue

2-3

1 reference

25 November 2017

page(s)

341-346

1 reference

X chromosome-linked muscular dystrophy (mdx) in the mouse

25 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

3 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Muscle development in mdx mutant mice

3 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Determination of protein: A modification of the lowry method that gives a linear photometric response

3 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Activity of some proteolytic enzymes in normal and dystrophic human muscle

3 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Post-proline-cleaving enzyme in normal and dystrophic human muscle

3 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Activity of lysosomal cysteine proteinase during differentiation of rat skeletal muscle

3 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Beneficial effect of chymostatin on dystrophic mice

3 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Protein synthesis and degradation in skeletal muscle of normal and dystrophic hamsters

3 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased Muscles

3 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Is there a membrane defect in muscle and other cells?

3 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine

3 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Susceptibilities of Various Myofibrillar Proteins to Cathepsin B and Morphological Alteration of Isolated Myofibrils by This Enzyme1

3 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Stringent requirement for Ca2+ in the removal of Z-lines and α-actinin from isolated myofibrils by Ca2+-activated neutral proteinase

3 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Treatment of mouse muscular dystrophy with the protease inhibitor pepstatin

3 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Degradation of myofibrillar proteins by cathepsins B and D

3 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Successful treatment of murine muscular dystrophy with the protease inhibitor bestatin

3 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Muscular Dystrophy: Inhibition of Degeneration in Vivo with Protease Inhibitors

3 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Lysosomal and Nonlysosomal Hydrolases of Skeletal Muscle in Neuromuscular Diseases

3 January 2023

23

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse

3 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Increased rates of myofibrillar protein breakdown in muscle‐wasting diseases

3 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

Susceptibilities of various myofibrillar proteins to muscle serine protease

3 January 2023

26

1 reference

https://api.crossref.org/works/10.1016/0022-510X(88)90138-4

3 January 2023

Identifiers

1 reference

25 November 2017

1 reference